ConductScience.org, home

Paper36450828

First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens.

Moiseev I and 7 others. Bone Marrow Transplant, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens. Papers, record 36450828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36450828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2026-10-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moiseev IIvanhttps://orcid.org/0000-0002-4332-0114
2Barabanshikova MMaria
3Dotsenko AAnna
4Smirnova AAnnahttps://orcid.org/0000-0002-2814-7683
5Vlasova YYulia
6Morozova EElenahttps://orcid.org/0000-0002-9605-485X
7Bondarenko SSergey
8Kulagin AAlexanderhttps://orcid.org/0000-0002-9589-4136

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bronchiolitis Obliterans SyndromeMajor topic
Graft vs Host DiseaseMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Humans
Cyclophosphamide
Bone Marrow Transplantation
Calcineurin Inhibitors
Adrenal Cortex Hormones
Acute Disease

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
17-75-20145Russian Science Foundation (RSF)PubMed

Source PubMed

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123892326Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.Bone Marrow Transplant2014https://conductscience.org/library/papers/23892326PubMed
234049582
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT.
J Hematol Oncol2021https://conductscience.org/library/papers/34049582PubMed
37004534Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.Blood1981https://conductscience.org/library/papers/7004534PubMed
43042041
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
Blood1988https://conductscience.org/library/papers/3042041PubMed
575810761994 Consensus Conference on Acute GVHD Grading.Bone Marrow Transplant1995https://conductscience.org/library/papers/7581076PubMed
634087452Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant.Transplant Cell Ther2021https://conductscience.org/library/papers/34087452PubMed
724225944Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide.Sci Transl Med2013https://conductscience.org/library/papers/24225944PubMed
825796139
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
Biol Blood Marrow Transplant2015https://conductscience.org/library/papers/25796139PubMed
925113844Transcriptome profiling of CTLs regulated by rapamycin using RNA-Seq.Immunogenetics2014https://conductscience.org/library/papers/25113844PubMed
1018489989HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.Biol Blood Marrow Transplant2008https://conductscience.org/library/papers/18489989PubMed
1130674564Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses.J Exp Med2019https://conductscience.org/library/papers/30674564PubMed
1221383686Prognostic value of response after upfront therapy for acute GVHD.Bone Marrow Transplant2012https://conductscience.org/library/papers/21383686PubMed
137023233Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids.Am J Hematol1981https://conductscience.org/library/papers/7023233PubMed
1420124511High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.Blood2010https://conductscience.org/library/papers/20124511PubMed
1534855460Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.J Clin Oncol2022https://conductscience.org/library/papers/34855460PubMed
1634535015Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival.Blood Adv2021https://conductscience.org/library/papers/34535015PubMed
1716338616National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.Biol Blood Marrow Transplant2005https://conductscience.org/library/papers/16338616PubMed
1831700138Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.Bone Marrow Transplant2020https://conductscience.org/library/papers/31700138PubMed
1933257777Incorporation of posttransplant cyclophosphamide as part of standard immunoprophylaxis for all allogeneic transplants: a retrospective, single institution study.Bone Marrow Transplant2021https://conductscience.org/library/papers/33257777PubMed
2026611557Infection Risk and Safety of Corticosteroid Use.Rheum Dis Clin North Am2016https://conductscience.org/library/papers/26611557PubMed

See all 44 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
39207560Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease.Ann Hematol2025https://conductscience.org/library/papers/39207560

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APP351PubTator's text mininghttps://conductscience.org/library/genes/351

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36450828

GET https://conductscience.org/api/papers/v1/36450828/references?page=2